These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7245142)

  • 21. The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo.
    Buchanan MR; Rosenfeld J; Hirsh J
    Thromb Res; 1978 Nov; 13(5):883-92. PubMed ID: 741458
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of sulphinpyrazone on the aggregation and release reactions of human platelets.
    Wiley JS; Chesterman CN; Morgan FJ; Castaldi PA
    Thromb Res; 1979 Jan; 14(1):23-33. PubMed ID: 570742
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased erythrocyte membrane arachidonate and platelet malondialdehyde (MDA) production in psoriasis: normalization after fish-oil.
    Schena D; Chieregato GC; de Gironcoli M; Girelli D; Olivieri O; Stanzial AM; Corrocher R; Bassi A; Ferrari S; Perazzoli P
    Acta Derm Venereol Suppl (Stockh); 1989; 146():42-4. PubMed ID: 2609880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets.
    McMillan RM; MacIntyre DE; Gordon JL
    Thromb Res; 1977 Sep; 11(3):425-8. PubMed ID: 918904
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative effects of sulfinpyrazone and ibuprofen on canine platelet function and prostaglandin-mediated coronary vasodilation.
    Goldstein RE; Davenport NJ; Capurro NL; Lipson LC; Bonow RO; Shulman NR; Epstein SE
    J Cardiovasc Pharmacol; 1980; 2(4):399-409. PubMed ID: 6156338
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive properties of Anturan].
    Quellmalz U; Dostal G; Heesen P
    Chir Forum Exp Klin Forsch; 1979; ():333-7. PubMed ID: 456148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of trimetazidine dihydrochloride on aggregation, serotonin release and malondialdehyde production in rabbit platelets.
    Shirahase H; Suzuki Y; Osumi S; Kakeya N; Kurahashi K
    Jpn J Pharmacol; 1988 May; 47(1):29-34. PubMed ID: 3137386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
    Kubik MM; Richardson SG
    Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of platelet aggregation and malondialdehyde production in patients with chronic cor pulmonale].
    Zhou YC; Weng XZ; Qiu HG
    Zhonghua Nei Ke Za Zhi; 1987 Nov; 26(11):638-40, 677. PubMed ID: 3443028
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification by antiplatelet drugs of acute EEG changes induced in the rat by sodium arachidonate.
    Schwartzmiller D
    Pharmacology; 1980; 20(2):101-5. PubMed ID: 7384190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
    Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
    Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malondialdehyde formation by blood platelets: a diagnostic test to assess acetylsalicylic acid induced thrombocytopathy?
    Hovinga JK; Felix R; Furlan M; Lämmle B
    Thromb Res; 1990 Jul; 59(1):89-95. PubMed ID: 2399531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two new metabolites of sulfinpyrazone in the rabbit: a possible cause of the prolonged in vivo effect.
    Pedersen AK; Jakobsen P
    Thromb Res; 1979; 16(5-6):871-6. PubMed ID: 524326
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
    Pönicke K; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
    Altman R; Scazziota A; Rouvier J; Cacchione R
    Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet aggregates and malondialdehyde production by platelets during ergonovine-induced coronary spasm.
    Salerno JA; Grignani G; Previtali M; Gamba G; Chimienti M; Bobba P
    Lancet; 1981 Feb; 1(8216):381-2. PubMed ID: 6110007
    [No Abstract]   [Full Text] [Related]  

  • 39. Vincristine inhibits the synthesis of malondialdehyde by human platelets in vitro.
    Martin JF; Greaves M
    Cancer; 1982 Feb; 49(4):665-8. PubMed ID: 6799184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Leis LA; Rao GH; White JG
    Thromb Res; 1979 Jan; 14(1):147-54. PubMed ID: 425077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.